HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Roach Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2016Should Treatment with Radiation and Androgen Deprivation Therapy be Considered the 'Gold Standard' for Men with Unfavourable Intermediate- to High-risk and Locally Advanced Prostate Cancer?
10/2014Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
9/2013Erectile dysfunction after radiotherapy for prostate cancer: a model assessing the conflicting literature on dose-volume effects.
1/2007New technologies for the radiotherapy of prostate cancer. A discussion of clinical treatment programs.
12/2006Role of radiation therapy in the treatment of unfavorable risk prostate cancer.
11/2006The use of megavoltage cone-beam CT to complement CT for target definition in pelvic radiotherapy in the presence of hip replacement.
6/2004Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.
3/2004The use of hormonal therapy with radiotherapy for prostate cancer: analysis of prospective randomised trials.
9/2003What does postradiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer?
9/2003Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Roach Research Topics

Disease

28Prostatic Neoplasms (Prostate Cancer)
01/2016 - 01/2000
5Neoplasms (Cancer)
10/2014 - 01/2000
3Erectile Dysfunction
09/2013 - 08/2000
2Pain (Aches)
02/2001 - 04/2000
2Diarrhea
05/2000 - 04/2000
1Neoplasm Metastasis (Metastasis)
06/2004
1Urge Urinary Incontinence (Urge Incontinence)
04/2001
1Overactive Urinary Bladder (Overactive Bladder)
04/2001
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2001
1Hemorrhage
01/2001
1Margins of Excision
07/2000
1Carcinoma (Carcinomatosis)
06/2000
1Extranodal Extension
05/2000
1Proctitis
05/2000
1Hematuria
04/2000
1Urinary Retention
04/2000
1Nocturia
04/2000

Drug/Important Bio-Agent (IBA)

4Prostate-Specific Antigen (Semenogelase)IBA
05/2003 - 05/2000
3AndrogensIBA
01/2016 - 01/2000
1Complement System Proteins (Complement)IBA
11/2006
1Indicators and Reagents (Reagents)IBA
09/2003
1Tolterodine Tartrate (Detrol)FDA Link
04/2001
1oxybutynin (Tavor)FDA LinkGeneric
04/2001
1ProstaglandinsIBA
02/2001
1Cyclooxygenase InhibitorsIBA
02/2001
1Sildenafil Citrate (Viagra)FDA Link
08/2000
1Narcotics (Narcotic Analgesics)IBA
04/2000
1Capsules (Microcapsules)IBA
01/2000

Therapy/Procedure

19Radiotherapy
10/2014 - 01/2000
9Therapeutics
01/2016 - 05/2000
4Prostatectomy (Retropubic Prostatectomy)
10/2000 - 06/2000
3Brachytherapy
06/2001 - 06/2000
3Conformal Radiotherapy
05/2001 - 04/2000
1Re-Irradiation
10/2014
1Salvage Therapy
10/2014
1Laser Coagulation
01/2001